Wegovy vs Ozempic: What's the Difference for Weight Loss in 2026?

Wegovy and Ozempic contain the same drug, semaglutide, made by Novo Nordisk. The difference is what each is approved for and how high the dose goes. Wegovy is approved for chronic weight management (plus heart-risk reduction and fatty liver disease) and goes up to 2.4 mg a week, or 7.2 mg as Wegovy HD. Ozempic is approved for type 2 diabetes and tops out at 2 mg. For weight loss without diabetes, Wegovy is the version built and covered for the job.

Novo Nordisk launched semaglutide as Ozempic for diabetes in 2017. When higher doses produced large weight loss, the company ran a separate obesity program (the STEP trials) and won approval for Wegovy in 2021. The pens look different, the dose ladders are different, and insurers treat them as separate products.

That's why using Ozempic for weight loss is off-label and usually not covered without diabetes, while Wegovy is the brand designed and priced for it.

Wegovy, because it goes higher. In STEP 1, adults without diabetes lost about 15% of their body weight on 2.4 mg over 68 weeks. Ozempic's diabetes trials, at 1 mg and 2 mg, produced average losses of about 6 to 7 kg. Part of that gap is that people with diabetes lose less on these drugs, but most is dose. Wegovy HD, approved in 2026 for people who've already been on 2.4 mg, averaged about 21% in its trial.

Wegovy pens in the U.S. are single-use, one per week; Ozempic pens hold several doses. Never try to "click" one pen to match the other's dose. Our Wegovy dosing schedule has the full details, including the pill.

Cash prices are now similar: both pens are $349 a month for most doses through Novo Nordisk's self-pay program. The difference is coverage. Ozempic is widely covered for type 2 diabetes. Wegovy is covered only by plans that include weight-loss drugs, for heart-risk reduction, or through Medicare's GLP-1 Bridge ($50 copay, July 2026 to December 2027). See our Wegovy cost and savings guide.

Same molecule, same side effects: nausea, diarrhea, vomiting and constipation early on, with rarer risks such as pancreatitis, gallbladder problems and dehydration-related kidney injury. Higher doses tend to bring more stomach side effects, which is why Wegovy's dose climbs slowly. Neither should be used with a personal or family history of medullary thyroid cancer or MEN 2. See side effects.

Wegovy and Ozempic are the same medicine packaged for different patients. Ozempic treats type 2 diabetes at up to 2 mg; Wegovy treats obesity at up to 2.4 mg (7.2 mg as HD) and produces more weight loss. With prices now similar, the decision usually comes down to your diagnosis and your insurance.